
The difficulties besetting generic firm and contract manufacturer Hospira have taken a new turn with the news that one of …

Generic pharma company Hospira’s efforts to bring its manufacturing network back into compliance took a knock this week when it …

Shortages of the short-acting anaesthetic propofol in the US could be helped by the return to market of a generic …
US injectable drugs specialist Hospira has announced plans to expand in India via the purchase of a manufacturing facility and …
Generic pharma company Hospira has been forced to recall another product as it works to rectify quality issues at three …

Hospira has concluded that a supplier defect was the root cause of its recall of four cancer drugs in the …
Hospira overfilled Carpuject cartridges, high-potency certification at Baxter, plus updates from Provence Technologies, Selexis and Florida Biologix.

Hospira has announced Richard Davies as its senior vice president and chief commercial officer. In this role, he will be responsible for …
Angry investors in US generic drugmaker Hospira have filed a class action lawsuit against the company, alleging that it misled …
India’s Vivimed buys Spanish API maker, Hospira tries to spend its way out of manufacturing woes, plus updates from PharmaS, …
US global specialty pharmaceutical company Hospira has appointed Svend Andersen to lead its operations in Europe with effect from 1 …
The pharmaceutical manufacturing sector had another week of mixed fortunes, with yet more recalls being announced and a former Wyeth …
US regulator the FDA has agreed to assess Teva’s application for a biosimilar version of Amgen’s Neupogen (filgrastim). XM02, a …
Genzyme has taken the decision to move the fill and finish stages of its manufacturing process to Hospira in order …

Indian active pharmaceutical ingredient manufacturer Orchid Chemicals & Pharmaceuticals has signed a $400 million deal to sell the assets of …